Investors should review proxy materials for details on board nominees, executive pay, and any shareholder proposals ahead of the vote. No material changes or surprises are indicated in this filing.
EBS drugs
EBS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 16 $8.62entry
- T+1 · 7mo ago +2.20%α +0.99% · $8.81
- T+5 · 7mo ago −6.15%α −7.13% · $8.09
- T+20 · 6mo ago −3.36%α −9.18% · $8.33
- T+60 · 4mo ago −7.08%α −14.12% · $8.01
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Emergent BioSolutions Inc. filed its definitive proxy statement for the 2026 annual shareholder meeting, scheduled for April 29, 2026. The filing serves as a reminder for shareholders to vote on matters including director elections and executive compensation, with voting accessible via proxy.
Key Financial Metrics
Key Facts
- Filing is a Definitive Proxy Statement (DEFA14A) for the 2026 annual meeting.
- Annual meeting date is April 29, 2026, at 9:00 AM Eastern Time.
- Shareholders of record as of March 6, 2026, are eligible to vote.
- Voting can be completed by proxy, with instructions sent via email through E*TRADE.
Financial Impact
No direct financial impact; routine corporate governance filing.
Risk Factors
- Low engagement from shareholders could affect voting outcomes on key proposals.
- Potential for activist shareholder activity if dissatisfaction with management arises.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-158134 |
| Document: 0001193125-26-158134-index-headers.html | 0001193125-26-158134 |
| Document: 0001193125-26-158134-index.html | 0001193125-26-158134 |
| Document: 0001193125-26-158134.txt | 0001193125-26-158134 |
Track record
23 reports on EBS
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
- Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
- Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
- Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
- Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
- Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers